Incorporation of biologic factors for the staging of de novo stage IV breast cancer
Sign Up to like & getrecommendations! Published in 2020 at "NPJ Breast Cancer"
DOI: 10.1038/s41523-020-00186-5
Abstract: This study aimed to investigate the prognostic value of biological factors, including histological grade, estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER2) status in de novo stage IV breast cancer.… read more here.
Keywords: novo stage; stage; stage breast; breast cancer ... See more keywords
Overall survival following locoregional surgery of the primary tumor in de novo stage IV breast cancer patients.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.1082
Abstract: 1082Background: Current guidelines lack definitive evidences about the relative benefits of locoregional surgery for the primary tumor in de novo stage IV breast cancer. The aim of this study was to comprehensively investigate the role… read more here.
Keywords: surgery; locoregional surgery; primary tumor; novo stage ... See more keywords
Genomic landscape of de novo stage IV breast cancer.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2019.37.15_suppl.1022
Abstract: 1022 Background: Genomic profiling of primary and recurrent metastatic breast cancer (rMBC) has revealed potential resistance mechanisms to therapy. In contrast, de novo stage IV breast cancer (DNIV) represents an opportunity to elucidate metastatic drivers… read more here.
Keywords: mut; breast cancer; dniv; novo stage ... See more keywords